Somatostatin receptor imaging

被引：178

作者：

Kwekkeboom, DJ ^{[1
]}

Krenning, EP ^{[1
]}

机构：

[1] Erasmus Univ, Med Ctr, Dept Nucl Med, Rotterdam, Netherlands

来源：

SEMINARS IN NUCLEAR MEDICINE | 2002年 / 32卷 / 02期

关键词：

D O I：

10.1053/snuc.2002.31022

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

[In-111-DTPA(0)]octreotide is a radiopharmaceutical with a great potential for the visualization of somatostatin receptor-positive tumors. The overall sensitivity of Somatostatin Receptor Imaging (SRl) to localize neuroendocrine tumors is high. In a number of neuroendocrine tumor types, as well as in Hodgkin's disease, inclusion of SRl in the localization or staging procedure may be very rewarding, either in terms of cost-effectiveness, patient management, or quality of life. The value of SRl in patients with other tumors, like breast cancer, or in patients with granulomatous diseases, has to be established. The development of Peptide Receptor Radionuclide Therapy (PRRT) is expected to stimulate peptide receptor imaging. Copyright 2002, Elsevier Science (USA). All rights reserved.

引用

页码：84 / 91

页数：8

共 70 条

[1] Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings [J].

Adams, S ;

Baum, RP ;

Hertel, A ;

Schumm-Draeger, PM ;

Usadel, KH ;

Hör, G .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (09) :1277-1283

[2] CLINICAL EFFICACY OF OCTREOTIDE SCINTIGRAPHY IN PATIENTS WITH MIDGUT CARCINOID-TUMORS AND EVALUATION OF INTRAOPERATIVE SCINTILLATION DETECTION [J].

AHLMAN, H ;

WANGBERG, B ;

TISELL, LE ;

NILSSON, O ;

FJALLING, M ;

FORSSELLARONSSON, E .

BRITISH JOURNAL OF SURGERY, 1994, 81 (08) :1144-1149

[3] SOMATOSTATIN RECEPTOR IMAGING OF SMALL-CELL LUNG-CANCER (SCLC) BY MEANS OF IN-111-DTPA OCTREOTIDE SCINTIGRAPHY [J].

BOMBARDIERI, E ;

CRIPPA, F ;

CATALDO, I ;

CHITI, A ;

SEREGNI, E ;

SORESI, E ;

BOFFI, R ;

INVERNIZZI, G ;

BURAGGI, GL .

EUROPEAN JOURNAL OF CANCER, 1995, 31A (02) :184-188

[4] SOMATOSTATIN - A PEPTIDE WITH UNEXPECTED PHYSIOLOGICAL ACTIVITIES [J].

BRAZEAU, P .

AMERICAN JOURNAL OF MEDICINE, 1986, 81 (6B) :8-13

[5] CLINICALLY NONFUNCTIONING PITUITARY-ADENOMA AND OCTREOTIDE RESPONSE TO LONG-TERM HIGH-DOSE TREATMENT, AND STUDIES INVITRO [J].

DEBRUIN, TWA ;

KWEKKEBOOM, DJ ;

VANTVERLAAT, JW ;

REUBI, JC ;

KRENNING, EP ;

LAMBERTS, SWJ ;

CROUGHS, RJM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (05) :1310-1317

[6] SOMATOSTATIN RECEPTOR SCINTIGRAPHY - ITS VALUE IN TUMOR-LOCALIZATION IN PATIENTS WITH CUSHINGS-SYNDROME CAUSED BY ECTOPIC CORTICOTROPIN OR CORTICOTROPIN-RELEASING HORMONE-SECRETION [J].

DEHERDER, WW ;

KRENNING, EP ;

MALCHOFF, CD ;

HOFLAND, LJ ;

REUBI, JC ;

KWEKKEBOOM, DJ ;

OEI, HY ;

POLS, HAP ;

BRUINING, HA ;

NOBELS, FRE ;

LAMBERTS, SWJ .

AMERICAN JOURNAL OF MEDICINE, 1994, 96 (04) :305-312

[7] SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN 48 PATIENTS WITH THE ZOLLINGER-ELLISON-SYNDROME [J].

DEKERVILER, E ;

CADIOT, G ;

LEBTAHI, R ;

FARAGGI, M ;

LEGULUDEC, D ;

MIGNON, M .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1994, 21 (11) :1191-1197

[8]

Duet M, 1999, J NUCL MED, V40, P1252

[9] Octreotide-scintigraphy is a disease-activity parameter in Graves' ophthalmopathy [J].

Gerding, MM ;

van der Zant, FM ;

van Royen, EA ;

Koornneef, L ;

Krenning, EP ;

Wiersinga, WM ;

Prummel, MF .

CLINICAL ENDOCRINOLOGY, 1999, 50 (03) :373-379

[10] Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas - A prospective study [J].

Gibril, F ;

Reynolds, JC ;

Doppman, JL ;

Chen, CC ;

Venzon, DJ ;

Termanini, B ;

Weber, C ;

Stewart, CA ;

Jensen, RT .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (01) :26-+

← 1 2 3 4 5 6 7 →